Endometrial pathologies associated with postmenopausal tamoxifen treatment
Top Cited Papers
- 19 June 2004
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 94 (2) , 256-266
- https://doi.org/10.1016/j.ygyno.2004.03.048
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.American Journal of Roentgenology, 1997
- Different Coexisting Endometrial Histological Features in Asymptomatic Postmenopausal Breast Cancer Patients Treated with TamoxifenGynecologic and Obstetric Investigation, 1997
- Time-Dependent Effect of Tamoxifen Therapy on Endometrial Pathology in Asymptomatic Postmenopausal Breast Cancer PatientsInternational Journal of Gynecological Pathology, 1996
- Continuous Tamoxifen Treatment in Asymptomatic, Postmenopausal Breast Cancer Patients Does Not Cause Aggravation of Endometrial PathologiesGynecologic Oncology, 1994
- Pathology of endometrium treated with tamoxifen.Journal of Clinical Pathology, 1994
- Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trialThe Lancet, 1994
- Endometrial Changes with Tamoxifen: Comparison between Tamoxifen-Treated and Nontreated Asymptomatic, Postmenopausal Breast Cancer PatientsGynecologic Oncology, 1994
- Endometrial lesions in patients undergoing tamoxifen therapyInternational Journal of Gynecology & Obstetrics, 1991
- Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer—Preliminary reportGynecologic Oncology, 1991
- TAMOXIFEN AND THE UTERUS AND ENDOMETRIUMThe Lancet, 1989